Henri Merdjan

528 total citations
22 papers, 441 citations indexed

About

Henri Merdjan is a scholar working on Pharmacology, Molecular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Henri Merdjan has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 5 papers in Molecular Medicine and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Henri Merdjan's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (5 papers) and Pneumonia and Respiratory Infections (4 papers). Henri Merdjan is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (5 papers) and Pneumonia and Respiratory Infections (4 papers). Henri Merdjan collaborates with scholars based in France, United States and Switzerland. Henri Merdjan's co-authors include Antoine Tarral, Manickam Rangaraju, Shampa Das, Jianguo Li, Christine Miossec, Monica Borgonovi, Ken Coleman, Anne-Marie Girard, Premavathy Levasseur and George L. Drusano and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Henri Merdjan

22 papers receiving 419 citations

Peers

Henri Merdjan
Susan Willavize United States
Martin G. Kees Germany
V. Malerczyk Germany
Pooja Manchandani United States
John W. Vance United States
C. Randall Marchbanks United States
Soma Bahmany Netherlands
Mia Parsonnet United States
Uwe Tröger Germany
Hidetoshi Furuie Japan
Susan Willavize United States
Henri Merdjan
Citations per year, relative to Henri Merdjan Henri Merdjan (= 1×) peers Susan Willavize

Countries citing papers authored by Henri Merdjan

Since Specialization
Citations

This map shows the geographic impact of Henri Merdjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Merdjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Merdjan more than expected).

Fields of papers citing papers by Henri Merdjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Merdjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Merdjan. The network helps show where Henri Merdjan may publish in the future.

Co-authorship network of co-authors of Henri Merdjan

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Merdjan. A scholar is included among the top collaborators of Henri Merdjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Merdjan. Henri Merdjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchand, Mathilde, Patrick Brossard, Henri Merdjan, et al.. (2017). Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis. European Journal of Drug Metabolism and Pharmacokinetics. 42(6). 943–954. 15 indexed citations
2.
Merdjan, Henri, Antoine Tarral, Shampa Das, & Jianguo Li. (2016). Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment. The Journal of Clinical Pharmacology. 57(2). 211–218. 42 indexed citations
3.
Tarral, Antoine & Henri Merdjan. (2015). Effect of Age and Sex on the Pharmacokinetics and Safety of Avibactam in Healthy Volunteers. Clinical Therapeutics. 37(4). 877–886. 24 indexed citations
4.
5.
Coleman, Ken, Premavathy Levasseur, Anne-Marie Girard, et al.. (2014). Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 58(6). 3366–3372. 79 indexed citations
6.
Salvador, Arnaud, et al.. (2007). Liquid chromatography–tandem mass spectrometric determination of a new antibacterial agent (AVE6971) in human white blood cells. Journal of Chromatography B. 855(2). 173–179. 3 indexed citations
7.
Bouzom, François, Christian Laveille, Henri Merdjan, & Roeline Jochemsen. (2000). Use of Nonlinear Mixed Effect Modeling for the Meta‐Analysis of Preclinical Pharmacokinetic Data: Application to S 20342 in the Rat. Journal of Pharmaceutical Sciences. 89(5). 603–613. 15 indexed citations
8.
Merdjan, Henri, et al.. (1998). Determination of ivabradine and its N-demethylated metabolite in human plasma and urine, and in rat and dog plasma by a validated high-performance liquid chromatographic method with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 719(1-2). 125–133. 35 indexed citations
9.
Mueller, Edgar A., et al.. (1993). Pharmacokinetics of Cyclosporine and Multiple‐Dose Diclofenac During Coadministration. The Journal of Clinical Pharmacology. 33(10). 936–943. 21 indexed citations
10.
Merdjan, Henri, et al.. (1993). A mathematical model for dynamics of cardiovascular drug action: Application to intravenous dihydropyridines in healthy volunteers. Journal of Pharmacokinetics and Biopharmaceutics. 21(5). 489–514. 31 indexed citations
11.
Merdjan, Henri, et al.. (1990). Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis. Fundamental and Clinical Pharmacology. 4(6). 663–671. 8 indexed citations
12.
Brouard, R., et al.. (1988). Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.. PubMed. 30(4). 197–206. 4 indexed citations
13.
Nicolas, Patrick, et al.. (1986). Improved determination of sulpiride in plasma by ion-pair liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 381(2). 393–400. 29 indexed citations
14.
Baumelou, A, et al.. (1986). Acute effects of clometacin on renal prostaglandin biosynthesis in healthy subjects. European Journal of Clinical Pharmacology. 30(4). 499–501. 2 indexed citations
15.
Paillet, Matthieu, et al.. (1986). Rapid determination of clofibric acid in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 375. 179–183. 6 indexed citations
16.
Baumelou, A, et al.. (1985). Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.. PubMed. 74 Suppl 2. 88–91. 1 indexed citations
17.
Merdjan, Henri, et al.. (1985). Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.. British Journal of Clinical Pharmacology. 19(2). 211–217. 12 indexed citations
18.
Paillet, Matthieu, et al.. (1985). Rapid determination of alminoprofen in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 343(2). 455–459. 3 indexed citations
19.
Barreteau, Hélène, et al.. (1985). Rapid determination of pyrazinamide in biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 345(2). 453–456. 9 indexed citations
20.
Merdjan, Henri, et al.. (1983). Measurement of ornidazole by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 273(2). 475–480. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Willavize Breakdown of academic impact, for papers by Martin G. Kees Breakdown of academic impact, for papers by V. Malerczyk Breakdown of academic impact, for papers by Pooja Manchandani Breakdown of academic impact, for papers by John W. Vance Breakdown of academic impact, for papers by C. Randall Marchbanks Breakdown of academic impact, for papers by Soma Bahmany Breakdown of academic impact, for papers by Mia Parsonnet Breakdown of academic impact, for papers by Uwe Tröger Breakdown of academic impact, for papers by Hidetoshi Furuie
Rankless by CCL
2026